Charles Schwab’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $201K | Buy |
88,570
+63,693
| +256% | +$145K | ﹤0.01% | 3373 |
|
|
2025
Q1 | $15.8K | Buy |
24,877
+60
| +0.2% | +$38 | ﹤0.01% | 3469 |
|
|
2024
Q4 | $25.6K | Hold |
24,817
| – | – | ﹤0.01% | 3479 |
|
|
2024
Q3 | $29.3K | Hold |
24,817
| – | – | ﹤0.01% | 3464 |
|
|
2024
Q2 | $30.3K | Hold |
24,817
| – | – | ﹤0.01% | 3563 |
|
|
2024
Q1 | $54.1K | Hold |
24,817
| – | – | ﹤0.01% | 3361 |
|
|
2023
Q4 | $38.5K | Hold |
24,817
| – | – | ﹤0.01% | 3427 |
|
|
2023
Q3 | $32K | Hold |
24,817
| – | – | ﹤0.01% | 3455 |
|
|
2023
Q2 | $42.7K | Hold |
24,817
| – | – | ﹤0.01% | 3436 |
|
|
2023
Q1 | $37.5K | Sell |
24,817
-17,404
| -41% | -$26.3K | ﹤0.01% | 3396 |
|
|
2022
Q4 | $67.6K | Hold |
42,221
| – | – | ﹤0.01% | 3306 |
|
|
2022
Q3 | $62K | Buy |
+42,221
| New | +$62K | ﹤0.01% | 3281 |
|
|
2022
Q2 | – | Sell |
-167,178
| Closed | -$447K | – | 3561 |
|
|
2022
Q1 | $447K | Buy |
167,178
+3,164
| +2% | +$8.46K | ﹤0.01% | 3124 |
|
|
2021
Q4 | $711K | Sell |
164,014
-244
| -0.1% | -$1.06K | ﹤0.01% | 3040 |
|
|
2021
Q3 | $837K | Sell |
164,258
-345,671
| -68% | -$1.76M | ﹤0.01% | 2932 |
|
|
2021
Q2 | $3.23M | Buy |
509,929
+16,420
| +3% | +$104K | ﹤0.01% | 2556 |
|
|
2021
Q1 | $3.82M | Buy |
493,509
+138,866
| +39% | +$1.07M | ﹤0.01% | 2425 |
|
|
2020
Q4 | $2.32M | Buy |
354,643
+31,401
| +10% | +$206K | ﹤0.01% | 2549 |
|
|
2020
Q3 | $2.15M | Sell |
323,242
-4,162
| -1% | -$27.7K | ﹤0.01% | 2470 |
|
|
2020
Q2 | $2.73M | Buy |
327,404
+44,081
| +16% | +$367K | ﹤0.01% | 2305 |
|
|
2020
Q1 | $2.17M | Buy |
283,323
+27,844
| +11% | +$214K | ﹤0.01% | 2241 |
|
|
2019
Q4 | $2.12M | Sell |
255,479
-17,103
| -6% | -$142K | ﹤0.01% | 2398 |
|
|
2019
Q3 | $2.01M | Buy |
272,582
+8,511
| +3% | +$62.8K | ﹤0.01% | 2374 |
|
|
2019
Q2 | $2.96M | Sell |
264,071
-38,228
| -13% | -$429K | ﹤0.01% | 2214 |
|
|
2019
Q1 | $3.25M | Buy |
302,299
+5,334
| +2% | +$57.3K | ﹤0.01% | 2182 |
|
|
2018
Q4 | $4.49M | Sell |
296,965
-15,454
| -5% | -$233K | ﹤0.01% | 1959 |
|
|
2018
Q3 | $5.78M | Buy |
312,419
+76,493
| +32% | +$1.42M | ﹤0.01% | 1967 |
|
|
2018
Q2 | $5.39M | Buy |
235,926
+37,560
| +19% | +$859K | ﹤0.01% | 1954 |
|
|
2018
Q1 | $5.64M | Buy |
198,366
+21,864
| +12% | +$622K | ﹤0.01% | 1873 |
|
|
2017
Q4 | $3.73M | Buy |
176,502
+8,279
| +5% | +$175K | ﹤0.01% | 2066 |
|
|
2017
Q3 | $3.06M | Buy |
168,223
+50,581
| +43% | +$919K | ﹤0.01% | 2116 |
|
|
2017
Q2 | $1.82M | Buy |
117,642
+17,551
| +18% | +$272K | ﹤0.01% | 2247 |
|
|
2017
Q1 | $1.73M | Buy |
100,091
+4,959
| +5% | +$85.7K | ﹤0.01% | 2250 |
|
|
2016
Q4 | $1.05M | Buy |
95,132
+23,966
| +34% | +$264K | ﹤0.01% | 2412 |
|
|
2016
Q3 | $1.12M | Buy |
71,166
+29,444
| +71% | +$462K | ﹤0.01% | 2379 |
|
|
2016
Q2 | $427K | Buy |
41,722
+18,794
| +82% | +$192K | ﹤0.01% | 2642 |
|
|
2016
Q1 | $296K | Buy |
22,928
+357
| +2% | +$4.61K | ﹤0.01% | 2780 |
|
|
2015
Q4 | $472K | Buy |
+22,571
| New | +$472K | ﹤0.01% | 2670 |
|